Filing Flows › Comparisons › HRTX vs ROIV
Heron Therapeutics vs Roivant Sciences: HRTX and ROIV compared
Heron Therapeutics is the larger company: $35.2M of revenue in its latest quarter (Q3 2026) against $35.1M for Roivant Sciences (Q2 FY27). Roivant Sciences is growing faster (22× against -8% a year earlier). Heron Therapeutics is more profitable, with an operating margin of -4.7% against -763.2%.
Where the money goes: HRTX and ROIV
Heron Therapeutics (HRTX) · Q3 2026
Heron Therapeutics, Q3 2026: revenue $35.2M (-8% year over year), operating margin -4.7%, net loss $5.0M, operating cash flow −$794K. The chart follows the revenue to costs, profit and cash.
Roivant Sciences (ROIV) · Q2 FY27
Roivant Sciences, Q2 FY27: revenue $35.1M (22× year over year), operating margin -763.2%, net loss $137M, operating cash flow $594M. The chart follows the revenue to costs, profit and cash.
| Heron Therapeutics (HRTX) | Roivant Sciences (ROIV) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 FY27 |
| Revenue | $35.2M | $35.1M |
| Revenue growth, Y/Y | -8% | 22× |
| Operating margin | -4.7% | -763.2% |
| Net earnings | −$5.0M | −$137M |
| Net margin | -14.2% | -390.7% |
| Operating cash flow | −$794K | $594M |
| Free cash flow | — | $594M |
Where the revenue comes from
Heron Therapeutics
- CINVANTI: $20.0M (57%)
- ZYNRELEF: $10.6M (30%)
- Aponvie: $4.5M (13%)
- SUSTOL: $152K (0%)
Roivant Sciences
- Product revenue, net: $31.0M (88%)
- License, milestone and other revenue: $4.2M (12%)
Questions
Which is bigger, Heron Therapeutics or Roivant Sciences?
Heron Therapeutics is the larger company: $35.2M of revenue in its latest quarter (Q3 2026) against $35.1M for Roivant Sciences (Q2 FY27).
Is Heron Therapeutics or Roivant Sciences growing faster?
Roivant Sciences is growing faster (22× against -8% a year earlier).
Which is more profitable, Heron Therapeutics or Roivant Sciences?
Heron Therapeutics is more profitable, with an operating margin of -4.7% against -763.2%.
More: Heron Therapeutics earnings · how Heron Therapeutics makes money · Roivant Sciences earnings · how Roivant Sciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.